Search NASA⌕ Search

SEARCH · Search NASA

Results for “Outcomes”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 145 records · Page 8

Protecting the Health of Astronauts: Enhancing Occupational Health Monitoring and Surveillance for Former NASA Astronauts to Understand Long-Term Outcomes of Spaceflight-Related Exposures

The astronaut community is unique, and may be disproportionately exposed to occupational hazards not commonly seen in other communities. The extent to which the demands of the astronaut occupation and exposure to spaceflight-related hazards affect the health of the astronaut population over the life course is not completely known. A better understanding of the individual, population, and mission impacts of astronaut occupational exposures is critical to providing clinical care, targeting occupational surveillance efforts, and planning for future space exploration. The ability to characterize the risk of latent health conditions is a significant component of this understanding. Provision of health screening services to active and former astronauts ensures individual, mission, and community health and safety. Currently, the NASA-Johnson Space Center (JSC) Flight Medicine Clinic (FMC) provides extensive medical monitoring to active astronauts throughout their careers. Upon retirement, astronauts may voluntarily return to the JSC FMC for an annual preventive exam. However, current retiree monitoring includes only selected screening tests, representing an opportunity for augmentation. The potential long-term health effects of spaceflight demand an expanded framework of testing for former astronauts. The need is two-fold: screening tests widely recommended for other aging populations are necessary to rule out conditions resulting from the natural aging process (e.g., colonoscopy, mammography); and expanded monitoring will increase NASA's ability to better characterize conditions resulting from astronaut occupational exposures. To meet this need, NASA has begun an extensive exploration of the overall approach, cost, and policy implications of e an Astronaut Occupational Health program to include expanded medical monitoring of former NASA astronauts. Increasing the breadth of monitoring services will ultimately enrich the existing evidence base of occupational health risks to astronauts. Such an expansion would therefore improve the understanding of the health of the astronaut population as a whole, and the ability to identify, mitigate, and manage such risks in preparation for deep space exploration missions.

Rossi, Meredith↗

Risk of Adverse Health Outcomes & Decrements in Performance due to Inflight Medical Conditions: ExMC Pharmacy Research Plan

The Exploration Medical Capabilities (ExMC) Element of NASA's Human Research Program is charged with identifying medical capabilities that can address the challenges of prevention, diagnosis, and treatment of disease and injuries that could occur during exploration missions beyond Earth's orbit. Faced with the obstacle of access to in-flight medical care, and limitations of vehicle space, time, and communications; it is necessary to prioritize what medical consumables are manifested for the flight, and which medical conditions are addressed. Studies of astronaut health establish the incidence of common and high risk medical conditions that require medical intervention during long-duration exploration missions. In 2000, the Institute of Medicine (IOM) convened a committee of experts, Committee on Creating a Vision for Space Medicine during Travel beyond Earth Orbit, to examine the issues surrounding astronaut health and safety for long duration space missions. Two themes run throughout the committee's final report: (1) that not enough is known about the risks to human health during long-duration missions beyond Earth's orbit or about what can effectively mitigate those risks to enable humans to travel and work safely in the environment of deep space and (2) that everything reasonable should be done to gain the necessary information before humans are sent on missions of space exploration (IOM, 2001). Although several spaceflight focused pharmaceutical research studies have been conducted, few have provided sufficient data regarding medication usage or potency changes during spaceflight. The Du pharmaceutical stability study assessed medications flown on space shuttles to and from the International Space Station (ISS) from 2006 until 2008; of which some medications were still viable beyond their expiration dates (Du et al, 2011). However, as with many spaceflight studies, the small 'n' associated with this study limits the ability to draw strong conclusions from it. Dr. Wotring and others have recently published articles containing information regarding medication usage, indications, and efficacy gleaned from spaceflight records (Wotring et al, 2015, 2016; Barger et al, 2014; Basner and Dinges, 2014). Although some conclusions can be drawn from these studies, the inability to fully quantify medication usage, indications, side effects, and effectiveness, limits insight as to which medications should be prioritized for further research.

Antonsen, Erik↗

NASA ACC High Energy Dynamic Impact Methodology and Outcomes

For High Energy Dynamic Impact (HEDI) events, testing to evaluate the structural response of primary aircraft structure for design and certification is both expensive and time consuming. This paper discusses current work seeking to assess, develop, and validate appropriate analytical models that accurately predict physical response, damage, and failure modes for large scale composite structures in HEDI events. Four state-of-the-art Progressive Damage Analysis (PDA) methods were employed for this phased project: LS-DYNA MAT162, LS-DYNA MAT261, Smoothed Particle Galerkin (SPG), and EMU Peridynamics. Multiple material systems were considered, namely T700/5208 textile-infusion triaxial braid, T800/AMD-825 textile-infusion triaxial braid, IM7/8552 uni-directional tape, and SPG 196-PW/8552 plain-weave fabric. Extensive ballistic impact testing was performed to support this activity and measured results were compared to predictive models for assessment using panel delamination, panel displacement, force at the load cells, and threshold velocity as measures. Ultimately, the work under this activity provided significant progress in advancing the state-of-the-art in the use of PDA for HEDI events. Each material model had favorable performance comparing to test in some parameters and needed improvement in others. With the lessons learned from this activity, significant progress was made in the ability to predict panel behavior for a more general case beyond the flat panel in a ballistic impact event. Subsequent Phase II of the NASA ACC HEDI effort will continue to build on the coupon testing, flat panel ballistic impact testing, and analysis performed to-date with application of the PDA methods for intended material selections to test articles with greater complexity of configuration, curvature, and scale. It is not the intention of this paper to present a full set of data, but rather to give an overview of the NASA HEDI effort and show a small representative subset of the test and analysis results.

Hunziker, Kenneth J.↗

NASA ACC High Energy Dynamic Impact Methodology and Outcomes

High fidelity analysis methods known as Progressive Damage Analysis (PDA) methods, capable of reliably predicting the onset and progression of damage in composite materials, are being developed for HEDI event simulation. Four state-of-the-art PDA methods are being investigated: LS-DYNA MAT162, LS-DYNA MAT261, Smooth-Particle Galerkin (SPG), and EMU Peridynamics. Validation of these PDA models aims to follow a building block approach, starting with coupon- and component-level development. As part of the overall effort, material characterization testing was performed to bridge gaps between existing experimental data and the material property inputs required to predict ballistic impact behavior at the component-level. The material models were updated with the results of the coupon-level testing and were then used to predict panel behavior and damage in ballistic impact events. To assess the accuracy of the PDA methods, these pre-test predictions were compared to the results of ballistic impact testing.

Hunziker, Kenneth J.↗

Outcomes of 7 Years of Airborne Trace Gas Measurements over California and Nevada: The Alpha Jet Atmospheric eXperiment (AJAX)

The Alpha Jet Atmospheric eXperiment (AJAX) has been flying a scientific payload since January 2011 measuring ozone, carbon dioxide, methane, formaldehyde and meteorological parameters up to 9 kilometers. AJAX is located and operated from the San Francisco Bay Area and has flown a total of 229 flights, on a regular basis (approximately 3 per month) over all seasons cataloguing a long-term record of trace gas concentrations over California and Nevada. The AJAX project focuses on science questions which benefit from routine, frequent observations with flexible scheduling. This presentation will provide an overview of AJAX activities including a discussion of airborne measurements for: Long-Range Transport (LRT) and Stratosphere-to-Troposphere Transport (STT). Regular sampling by AJAX has aided identification of LRT and evidence of STT, which during spring and summer months are visible as elevated O3 laminae within airborne profiles. Some laminae have the ability to impact surface level air quality; Satellite validation - Regular AJAX missions include flights to Railroad Valley, NV in coordination with GOSAT (Greenhouse Gases Observing Satellite) and OCO-2 (Carbon Observatory-2) observations, and more recently to provide coincident measurements under TROPOMI (TROPOspheric Monitoring Instrument); The AJAX project is uniquely flexible to incorporate specialized flights with limited planning notice, such as sampling emissions from California wildfires. Nine wildfires have been sampled, with some more than once allowing to observe emission changes as the fire progresses; Pandora validation - Future work will include development of flight strategies for validation of ground based Pandora spectrometers.

Yates, Emma L.↗

Neurovascular Outcomes of Space Radiation in Human Blood-Brain Barrier Models

One of the main health risks in human deep space exploration is central nervous system (CNS) damage by ionizing radiation due to exposure to galactic cosmic rays (GCRs). In animal models, irradiation with simulated GCRs or their components has been shown to cause neurodegeneration and neuroinflammation associated with cognitive and behavioral dysfunction. The extent of CNS damage is partially mediated by the blood-brain barrier (BBB), which regulates the interaction between CNS and systemic responses to stressors in the rest of the body. The main cellular regulators of BBB permeability are astrocytes, which also modulate neuronal death, neuroinflammation and oxidative stress. However, studies on BBB and astrocyte functions in regulating CNS responses to ionizing radiation have been limited, especially in human tissue/organ analogs. Therefore, we developed a high-throughput 3D organ-on-a-chip system to study human CNS and BBB impairments caused by deep space radiation. We investigated both immediate and delayed CNS responses to major GCR components: 0.15-0.5Gy 250MeV/n 4He and 0.3-0.8Gy 600MeV/n 56Fe; as well as to 0.5-1Gy X-rays. We observed ionizing radiation-mediated increases in BBB permeability that was exacerbated by astrocyte presence and accompanied by damage to endothelial cells and tight junctions, altered cytokine expression including TNFalpha upregulation, and increased oxidative stress. In particular, 600MeV/n 56Fe particle irradiation selectively induced astrocyte damage and increased blood-brain barrier permeability only in models that contained astrocytes in addition to endothelial cells, indicating astrocytes as a particularly radiosensitive component of the CNS that could therefore be a suitable a target for neuroprotection. Future studies will compare human and mouse CNS model responses to simulated GCRs and evaluate the induction of an anti-inflammatory phenotype in astrocytes as a potential countermeasure. Ultimately, we aim to expand upon these results to uncover novel cellular and mechanistic targets for countermeasure development to mitigate human CNS damage in deep space exploration.

centrat nervous system↗

Neurovascular Outcomes of Ionizing Radiation in Human Blood-Brain Barrier Models

One of the main health risks in human deep space exploration is central nervous system (CNS) damage by ionizing radiation due to exposure to galactic cosmic rays (GCRs). In animal models, irradiation with simulated GCRs or their components has been shown to cause neurodegeneration and neuroinflammation associated with cognitive and behavioral dysfunction. The extent of CNS damage is partially mediated by the blood-brain barrier (BBB), which regulates the interaction between CNS and systemic responses to stressors in the rest of the body. The main cellular regulators of BBB permeability are astrocytes, which also modulate neuronal death, neuroinflammation and oxidative stress. However, studies on BBB and astrocyte functions in regulating CNS responses to ionizing radiation have been limited, especially in human tissue/organ analogs. Therefore, we developed a high-throughput 3D organ-on-a-chip system to study human CNS and BBB impairments caused by deep space radiation. We investigated both immediate and delayed CNS responses to major GCR components: 0.15-0.5Gy 250MeV/n 4He and 0.3-0.8Gy 600MeV/n 56Fe; as well as to 0.5-1Gy X-rays. We observed ionizing radiation-mediated increases in BBB permeability that was exacerbated by astrocyte presence and accompanied by damage to endothelial cells and tight junctions, altered cytokine expression including TNFalpha upregulation, and increased oxidative stress. In particular, 600MeV/n 56Fe particle irradiation selectively induced astrocyte damage and blood-brain barrier permeability only in models that contained astrocytes in addition to endothelial cells, indicating astrocytes as a particularly radiosensitive component of the CNS that could therefore be a suitable a target for neuroprotection. Future studies will compare human and mouse CNS model responses to simulated GCRs and evaluate the induction of an anti-inflammatory phenotype in astrocytes as a potential countermeasure. Ultimately, we aim to expand upon these results to uncover novel cellular and mechanistic targets for countermeasure development to mitigate human CNS damage in deep space exploration.

space radiation↗

Neurovascular Outcomes of Ionizing Radiation in Human Blood-Brain Barrier Models

One of the main health risks in human deep space exploration is central nervous system (CNS) damage by ionizing radiation due to exposure to galactic cosmic rays (GCRs). In animal models, irradiation with simulated GCRs or their components has been shown to cause neurodegeneration and neuroinflammation associated with cognitive and behavioral dysfunction. The extent of CNS damage is partially mediated by the blood-brain barrier (BBB), which regulates the interaction between CNS and systemic responses to stressors in the rest of the body. The main cellular regulators of BBB permeability are astrocytes, which also modulate neuronal death, neuroinflammation and oxidative stress. However, studies on BBB and astrocyte functions in regulating CNS responses to ionizing radiation have been limited, especially in human tissue/organ analogs. Therefore, we developed a high throughput 3D human neurovascular system model, based on commercially available Mimetas OrganoPlates seeded by primary human cells, to investigate the neurovascular responses to simulated deep space radiation. Using this system, we have demonstrated that 600MeV/n 56Fe irradiation leads to cellular damage and increased blood-brain barrier permeability via dysfunction of brain cells called astrocytes, which appear to be the weakest link and therefore a highly suitable countermeasure target to reduce the impact of space radiation on the blood-brain barrier. We anticipate that our results form merely the first step in ongoing development of organ models, including their adaptation for personalized risk assessment, high throughput approaches to countermeasure screening and validation, and eventual payload adaptation.

organ-on-a-chip↗